type here...

CATEGORIES

Rare and Orphan Diseases

LATEST

12Page 1 of 2

TRENDING

EDITORS CHOICE

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

Gil Bashe, Medika Life Editor -
EDS Subtyping May Not Be a Harmless Convention, But a Recipe for Patient Danger

Biotech Without Borders: Reclaiming the Wonder of Science in a Distracted Age

Gil Bashe, Medika Life Editor -
I was in the media bullpen with the team when the future arrived. The launch of Roferon-A, alpha interferon marked a watershed moment in medicine:...

It’s Time to Reconsider Deadly Munchausen’s Syndrome by Proxy

Pat Farrell PhD -
The little-talked-about or diagnosed syndrome may be more prevalent in healthcare than we know.

The Best Dating Game in Health Innovation Happens Just Off the Main Stage

Gil Bashe, Medika Life Editor -
Every January, San Francisco undergoes a transformation. For one week, the city shifts into high gear for the life sciences sector, becoming a dense,...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories